Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2023.06.22

SBTi

Sai Life Sciences joins Science Based Targets initiative (SBTi), commits to fight climate change with Science

To help combat climate change, Sai Life Sciences, a global Contract Research, Development & Manufacturing Organization (CRO-CDMO), announced joining Science Based Targets initiative (SBTi), a global body enabling businesses to set ambitious emission reduction targets in line with the latest climate science.

Accordingly, it has committed to set near-term company-wide emission reductions in line with climate science with the SBTi. These are 5-10-year GHG (Greenhouse gas) mitigation targets in accordance with the Paris Agreement’s aim to limit global temperature rise to 1.5°C to avoid the catastrophic impacts of climate change.

Making the announcement, Krishna Kanumuri, CEO & Managing Director, Sai Life Sciences, said, “Sai Life Sciences has joined the SBTi to address a collective imperative. The association will help in sharpening our approach to assess the impact of climate change and develop a strategy to address it. It will also strengthen our ability to nurture an organizational culture, where each employee is mindful of every act and its impact on the environment.”

Joining the SBTi will enable Sai Life Sciences to set targets, assess progress and calibrate actions to meet its goals in a time-bound manner. It will allow the company the opportunity to learn from SBTi’s rich experience of helping its member companies drive change and create impact on ground.

Earlier this month, on the World Environment Day, Sai Life Sciences announced its renewed Sustainable Development Goals (SDG) that chart out its roadmap to achieve specific environmental, social and governance (ESG) targets by the year ending March 31, 2027. As part of the SDGs, the company has committed to reduce specific greenhouse gas emissions by 30% and replace 70% of its energy requirement with renewable sources. Previously, as part of it first edition of SDGs for the period 2019 to 2022, the company exceeded its targets in areas such as the utilization of renewable energy, recycling of hazardous waste and reduction in greenhouse gas emissions, despite significantly expanding its operations.

In recent years, Sai Life Sciences has made significant investments and progress in advancing its Sustainability agenda as part of its organizational transformation initiative, Sai Nxt. Some of the notable highlights:

  1. Became the first India-headquartered company to join the PSCI membership.
  2. Joined ACS Green Chemistry Institute Pharmaceutical Roundtable (ACS-GCIPR) as an ‘Associate Member’.
  3. Publishing annual sustainability reports since 2020.
  4. Won several prestigious awards for excellence in EHS practices and energy management.
Share article

More News

2024.10.28

Sai Life Sciences receives EIRs from USFDA for India R&D & Manufacturing facilities

Sai Life Sciences, the fastest-growing Indian Contract Research, Development and Manufacturing Organization (CRDMO)[1], announced that it has received Establishment Inspection Reports (EIR) from the US Food and Drug Administration (USFDA) for its R&D (Unit II, Hyderabad), and Manufacturing (Unit IV, Bidar) sites in India. The General Good Manufacturing Practices (GMP) audit was conducted at the […]
Read more

2024.10.07

Sai Life Sciences releases Sustainability Report 2024

Sai Life Sciences, the fastest-growing Indian Contract Research, Development and Manufacturing Organization (CRDMO)[1], published its Sustainability Report for 2023-2024. Aligned with the Global Reporting Initiative (GRI) Universal Standards 2021 framework, this fifth edition of the Sustainability Report is based on the theme, ‘Synergising Sustainability, Performance and Growth.’ The full report can be read here. Making […]
Read more

2024.08.09

Sai Life Sciences elevates Compound Management process with in-house software application, CORAL

Compound management is a vital function in pharmaceutical research. A streamlined environment can bring significant value to the process in the form of productivity and efficiency. Recognizing the importance of this function, we have made our Compound Management suite for Discovery services smarter with the introduction of an in-house software application, Compound Organization and Registration […]
Read more

2024.07.29

Sai Life Sciences inducts 96 trainees across campuses in India

“I just got my first pair of safety shoes and I’m thrilled! Exploring the facility for the first time is such a joy!” – Spurthi R, Trainee, Medicinal Chemistry, Shamirpet. Ushering in a season of new beginnings, we welcomed 96 trainees across our campuses in India. These young individuals have been selected from eight colleges […]
Read more

2024.02.08

Sai Life Sciences releases its Sustainability Report 2023

Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO/ CDMO), released its Sustainability Report 2022-2023. Developed in accordance with the Global Reporting Initiative (GRI) Universal Standards 2021 framework, the fourth edition of the Sustainability report is based on the theme ‘Steadfast on Sustainability,’ and it articulates the company’s commitment to sustainability […]
Read more